http://www.thealtheafoundation.org/

She has been responsible for the Foundation’s frontier work in understanding the policy levers that influence the advancement of innovation from universities into the commercial market. Under Mitchell’s leadership, the Foundation is identifying critical research opportunities, defining and codifying alternative commercialization pathways, and identifying new models to foster innovation. Mitchell was instrumental in the founding of the Kauffman Innovation Network and the iBridge Network, a founding sponsor of the National Academy-based University–Industry Partnership, and leader in the replication of innovator-based mentor programs at universities across the country. In addition, Mitchell serves on the boards of Gazelle Growth in Denmark and the University of Kansas Research Institute.

Designed, developed and implemented global electronic clinical trial solutions for global pharma projects. Implemented electronic clinical trial capabilities at the Aventis/Quintiles SA office over a one year period. Additional projects completed with Takeda U.S.A and Eli Lilly.

Provided global guidance for clinical teams interested in implementing first generation real time electronic clinical trials. Strategic guidance for Quintiles leadership. Led global data management standards activities.Managed Clinical Data Management office in Mountain View, CA and Kansas City MO. Included full P&L responsibilities, mgmt of 300 person staff, selling to global pharma and interfacing with global clinical and stats leadership.